• Ruthenium Red: Strategic Dissection of Calcium Signaling ...

  2025-10-20

  This thought-leadership article delivers a mechanistic and strategic exploration of Ruthenium Red as a gold-standard calcium transport inhibitor. Bridging cytoskeleton-dependent calcium signaling, mechanical stress-induced autophagy, and inflammation, we provide actionable insights and experimental guidance for translational researchers. By integrating evidence from recent mechanobiology literature and positioning Ruthenium Red within the evolving competitive landscape, we empower researchers seeking innovation in foundational discovery and clinical translation.

• Sulfo-NHS-SS-Biotin: Revolutionizing Cell Surface Proteomics

  2025-10-19

  Discover how Sulfo-NHS-SS-Biotin, a leading amine-reactive biotinylation reagent, is advancing cell surface protein profiling and therapeutic target discovery. This article uniquely explores its mechanistic role in modern proteomics and translational research.

• Applied Workflows with (-)-Arctigenin: Advanced Anti-Infl...

  2025-10-18

  (-)-Arctigenin sets a new standard for mechanistic and translational research, offering potent anti-inflammatory and antiviral properties with precise targeting of NF-κB and MAPK/ERK signaling. This guide delivers actionable protocols, advanced troubleshooting, and comparative insights—empowering researchers to dissect tumor microenvironment crosstalk and accelerate bench-to-bedside innovation.

• Cisapride (R 51619): Mechanistic Precision and Strategic ...

  2025-10-17

  This thought-leadership article explores how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor, is reshaping the landscape of cardiac electrophysiology and predictive cardiotoxicity research. Blending mechanistic insight with strategic guidance, we examine the compound’s role as an indispensable tool for translational investigators. We integrate evidence from deep learning-enabled iPSC-cardiomyocyte phenotypic screening, delineate experimental best practices, and position Cisapride as a precision probe for de-risking early-stage drug development. This article builds on foundational discussions while offering an expanded, future-oriented perspective that transcends conventional product narratives.

• Bay 11-7821 (BAY 11-7082): Targeting NF-κB and Inflammaso...

  2025-10-16

  Explore the mechanistic depth and translational potential of Bay 11-7821 as a dual IKK and NF-κB pathway inhibitor in cancer research. This article uniquely connects Bay 11-7821’s action to recent breakthroughs in immune memory and tumor microenvironment modulation.

• br GMF Remodels Actin Networks at the Leading

  2023-07-06

  

  GMF Remodels Actin Networks at the Leading Edge How are the conserved activities of GMF used in vivo to regulate branched Progesterone networks (e.g., at sites of endocytosis and at the leading edge) (Figure 2A,B)? In animal cells, the regulatory effects of GMF on actin networks appear to govern

• The zebrafish Danio rerio is a popular

  2023-07-06

  

  The zebrafish (Danio rerio) is a popular model organism for virtually any biological function of vertebrates, and has, therefore, received a wide distribution in particular in developmental biology and toxicology (Strähle et al., 2012). With respect to AChE, the zebrafish has, e.g., been identified

• Microcystin-LR Although effects of low concentrations of ago

  2023-07-06

  

  Although effects of low concentrations of agonist were not as thoroughly documented for heteromeric receptors such as the major Microcystin-LR α4β2 nAChR, a similar mechanism of action was described to explain the potentiation of these receptors with low concentrations of acetylcholine-esterase-inh

• br Activity and expression of aromatase in

  2023-07-05

  

  Activity and expression of aromatase in the hippocampus The brain, like the adrenals, gonads and the placenta, is a steroidogenic organ. This paradigm emerged from studies carried out as early as the 1980s by Baulieu and co-workers; these studies showed that steroids such as pregnenolone and dehy

• As a neuropeptide Apelin also has a critical role in

  2023-07-05

  

  As a neuropeptide, Apelin also has a critical role in cardiovascular diseases. Systemic administration of Apelin exert vasodilatory and antihypertensive effects [33]. Meanwhile, the apelin-APJ signal transduction pathway is related to age-associated cardiovascular diseases [34]. It has been known th

• As the experimental procedure used

  2023-07-05

  

  As the experimental procedure used could reflect agonist-stimulation of both anterograde and retrograde APJ trafficking, as has been described for the δ-opioid peptide receptor (Zhang et al., 2006b, Zhang et al., 2006a), receptor internalization was more directly monitored by loading cell surface HA

• Pyridoxine HCl Using the same techniques we found that UCP a

  2023-07-05

  

  Using the same techniques, we found that UCP3 also has a half-life of between 1 and 4h [117]. In Pyridoxine HCl to UCP2 and UCP3, UCP1 and ANT had much longer half-lives and could not be degraded in the cell-free reconstituted system, suggesting their degradation is not mediated by the cytosolic pro

• Since E was shown to affect the expression of Hsps

  2023-07-05

  

  Since E2 was shown to affect the expression of Hsps, the transcript expression levels of another 11 Hsps were also evaluated by real-time PCR with their specific primers. The transcripts of 4 proteins (Hsp10, Hsp56, Hsp70a and Hsp110) were significantly up-regulated, but that of Hsp47 was significan

• Numerous investigators have shown that

  2023-07-05

  

  Numerous investigators have shown that RACK1 has several important, possibly related, roles in mRNA splicing and in translation. RACK1 interacts directly with specific components of the 40S ribosomal subunit (specifically, the 18S rRNA and ribosomal proteins rpS16e, rpS17e, and rpS3e [new names: uS9

• Numerous epidemiological studies document fewer

  2023-07-05

  

  Numerous epidemiological studies document fewer cardiovascular events and increased survival of non-CKD individuals treated with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARBs) [8], [9]. By contrast, there are few studies of cardiovascular benefits of interruption

11403 records 1/761 page Next 12345 下5页 Last page